According to a new report published by Allied Market Research, titled, "mHealth Market by Type, Stakeholders, and Application: Opportunity Analysis and Industry Forecast, 2019–2027,"the global mHealth market was valued at $46 billion in 2019, and is expected to reach $230 billion by 2027, registering a CAGR of 22.3% from 2020 to 2027.
Download Free Sample Report:
https://www.alliedmarketresearch.com/request-sample/77
Mobile health is a branch of electronic health, which is defined as medical and public health practice supported by mobile devices. The mobile devices used in mHealth include mobile phones, patient monitoring devices, personal digital assistants, and other devices. These devices are utilized to collect and store patient information to obtain accurate results, which are used to treat and diagnose various medical conditions such as diabetes, blood pressure, and others. In addition, other mHealth services include prevention of diseases, monitoring of diseases, and others.
Furthermore, these services are used in various clinical fields such as diabetes, respiratory diseases, cardiovascular diseases, and others. Moreover, some of the mHealth devices offered by various key players in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.
Mobile health (mHealth) is an area of electronic health (eHealth) that offers revolutionized healthcare services through uniquesmartphone based technologies that enable the remote monitoring of patients. Increasing adoption of smartphones, growing awareness of newer technologies and increasing consumer preferences towards healthy lifestyles are prime factors that supplement the adoption of mHealth devices.
For Purchase Enquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/1173
Based on application, the cardiovascular diseases segment accounted for more than half of the global mHealth market in 2019, and is expected to continue its lead status throughout the forecast period. This is due to surge in prevalence of cardiovascular diseases worldwide and increase in adoption of mHealth services to manage such medical conditions. However, the neurological diseases segment would register the fastest CAGR of 23.9% from 2020 to 2027, owing to increased focus of key players on the launch of novel and advanced mHealth devices to manage neurological conditions.
Based on region, North America held nearly two-fifths of the global mHealth market in 2019, and is estimated to maintain its dominant position throughout the forecast period. This is due to rise in awareness about the need to frequent monitoring of symptoms of chronic diseases to gain optimum treatment outcomes. However, Asia-Pacific is expected to contribute to the fastest CAGR of 25.7% from 2020 to 2027, owing to surge in mHealth application with huge population suffering from chronic diseases such as diabetes and hypertension.
Major Key Players:
BOSTON SCIENTIFIC CORPORATION,
DEXCOM, INC.,
FITBIT, INC. (TWINE HEALTH, INC.),
KONINKLIJKE PHILIPS N.V. (PHILIPS),
LIVONGO HEALTH, INC.,
MEDTRONIC PLC.,
OMADA HEALTH, INC.,
OMRON CORPORATION (OMRON HEALTHCARE, INC.),
SAMSUNG ELECTRONICS CO., LTD.,
WELLDOC, INC.
For Customization Request:
https://www.alliedmarketresearch.com/request-for-customization/77
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
